Site-specific lysine arylation as an alternative bioconjugation strategy for chemically programmed antibodies and antibody-drug conjugates
External Resource: Annotation
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
| B [auth L] | zf-CCCH_8 | e6u85L1 | A: a/b three-layered sandwiches | X: P-loop domains-like | H: DUF1107-like | T: DUF1107-like | F: zf-CCCH_8 | ECOD (v294.1) |
| A [auth H] | zf-CCCH_8 | e6u85H1 | A: a/b three-layered sandwiches | X: P-loop domains-like | H: DUF1107-like | T: DUF1107-like | F: zf-CCCH_8 | ECOD (v294.1) |
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|
| B [auth L] | Fab h38C2 | L-KAPPA | Humanized (humanized) | IGKV1-39*01, IGKV1D-39*01, IGKJ4*01, IGKJ4*02, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-1_KAPPA | IMGT (202612-0) |
| A [auth H] | Fab h38C2 | VH-CH1 | Humanized (humanized) | IGHV3-23*03, IGHV3-74*01, IGHV3-74*02, IGHV3-74*03, IGHV3-23*04, IGHJ4*01, IGHJ4*02, IGHJ4*03, IGHG1*03, IGHG1*08, IGHG1*06 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_KAPPA | IMGT (202612-0) |
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|
| B [auth L] | Light Chain | IGKV1 | Kappa | - | SAbDab (2026-03-27) |
| A [auth H] | Heavy Chain | IGHV6 | - | - | SAbDab (2026-03-27) |